ALNUS RHOMBIFOLIA POLLEN: 21 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
21
Total FAERS Reports
0
Deaths Reported
0
Hospitalizations
21
As Primary/Secondary Suspect
Greer Laboratories, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: Greer Laboratories, Inc. ·
First Report: 20160824 · Latest Report: 20250416
What Are the Most Common ALNUS RHOMBIFOLIA POLLEN Side Effects?
#1 Most Reported
Urticaria
10 reports (47.6%)
#2 Most Reported
Throat irritation
7 reports (33.3%)
#3 Most Reported
Pruritus
6 reports (28.6%)
All ALNUS RHOMBIFOLIA POLLEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Urticaria | 10 | 47.6% | 0 | 0 |
| Throat irritation | 7 | 33.3% | 0 | 0 |
| Anaphylactic reaction | 6 | 28.6% | 0 | 0 |
| Cough | 6 | 28.6% | 0 | 0 |
| Pruritus | 6 | 28.6% | 0 | 0 |
| Swelling face | 5 | 23.8% | 0 | 0 |
Who Reports ALNUS RHOMBIFOLIA POLLEN Side Effects? Age & Gender Data
Gender: 44.0% female, 56.0% male. Average age: 41.8 years. Most reports from: US. View detailed demographics →
Is ALNUS RHOMBIFOLIA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 5 | 0 | 0 |
| 2021 | 11 | 0 | 0 |
| 2022 | 2 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for ALNUS RHOMBIFOLIA POLLEN
Official prescribing information from the FDA-approved drug label.